| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Pelthos Therapeutics Inc. | Director | Common Stock | 54,573 | $1,746,336 | $32.00 | 25 Nov 2025 | Direct |
| Pelthos Therapeutics Inc. | Director | Common Stock | 40,000 | $1,280,000 | $32.00 | 25 Nov 2025 | By Key Recovery Group LLC |
| Pelthos Therapeutics Inc. | Director | Common Stock | 30,000 | $840,150 | $28.00 | 25 Nov 2025 | By Balmoral Financial Group LLC |
| Pelthos Therapeutics Inc. | Director | Restricted Stock Units | 28,012 | $615,709 | $0.9700 | 02 Jul 2025 | Direct |
| Pelthos Therapeutics Inc. | Director | Stock Option | 58,230 | 02 Jul 2025 | Direct | ||
| Pelthos Therapeutics Inc. | Director | Series A Convertible Preferred Stock | 0 | 01 Jul 2025 | By Balmoral Financial Group LLC | ||
| Pelthos Therapeutics Inc. | Director | Series A Convertible Preferred Stock | 0 | 01 Jul 2025 | By Key Recovery Group LLC |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CHRO | Pelthos Therapeutics Inc. | 25 Nov 2025 | 4 | -$280,280 | 4 | Director | 26 Nov 2025, 12:37 |
| CHRO | Pelthos Therapeutics Inc. | 02 Jul 2025 | 2 | $0 | 4 | Director | 07 Jul 2025, 21:42 |
| CHRO | Pelthos Therapeutics Inc. | 01 Jul 2025 | 6 | +$800,000 | 4 | Director | 03 Jul 2025, 21:05 |
| CHRO | Chromocell Therapeutics Corp | 13 Nov 2024 | 1 | $0 | 4 | Director | 15 Nov 2024, 16:19 |
| CHRO | Chromocell Therapeutics Corp | 14 Jun 2024 | 1 | $0 | 4 | Director | 18 Jun 2024, 20:03 |
| CHRO | Chromocell Therapeutics Corp | 21 Feb 2024 | 1 | +$100,002 | 4/A | Director | 12 Mar 2024, 16:05 |
| CHRO | Chromocell Therapeutics Corp | 21 Feb 2024 | 4 | +$99,077 | 4 | Director | 23 Feb 2024, 17:12 |
| CHRO | Chromocell Therapeutics Corp | 15 Feb 2024 | 0 | $0 | 3 | Director, 10%+ Owner | 15 Feb 2024, 20:06 |